COMPANIES COVERED
AbbVieDownload FREE Report Sample
Download Free sampleRheumatoid arthritis (RA) is an inflammatory disease that progresses over time affecting the joints. The symptoms aggravate over time, which is why medication for RA becomes essential to stop the inflammation. There is no permanent cure for rheumatoid arthritis, though increasing research activities regarding the same indicate that remission of symptoms is achieved when treatment begins in the initial stages with strong medications known as disease-modifying antirheumatic drugs (DMARDs).
Rheumatoid Arthritis Drugs Market contains market size and forecasts of Rheumatoid Arthritis (RA) Drugs in Global, including the following market information:
Global Rheumatoid Arthritis (RA) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rheumatoid Arthritis (RA) Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NSAIDs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis (RA) Drugs include AbbVie, Roche, Merck, HEYL Chemisch-pharmazeutische Fabrik, Johnson & Johnson, Amgen, Inc., Pfizer, Bristol-Myers Squibb and UCB, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rheumatoid Arthritis (RA) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis (RA) Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rheumatoid Arthritis (RA) Drugs Market Segment Percentages, by Type, 2021 (%)
NSAIDs
Analgesic Drugs
Corticosteroids
DMARDs
Biological Therapies
JAK-inhibitors
Global Rheumatoid Arthritis (RA) Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rheumatoid Arthritis (RA) Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Rheumatoid Arthritis (RA) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rheumatoid Arthritis (RA) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis (RA) Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rheumatoid Arthritis (RA) Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Roche
Merck
HEYL Chemisch-pharmazeutische Fabrik
Johnson & Johnson
Amgen, Inc.
Pfizer
Bristol-Myers Squibb
UCB
GSK
Sanofi
Abbott Laboratories
Teva Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
